Sumitomo Mitsui Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,970
Closed -$42K 192
2024
Q3
$42K Sell
4,970
-17,844
-78% -$148K ﹤0.01% 150
2024
Q2
$231K Sell
22,814
-4,044
-15% -$49.3K 0.01% 122
2024
Q1
$406K Sell
26,858
-3,726
-12% -$67.6K 0.01% 116
2023
Q4
$676K Sell
30,584
-7,080
-19% -$131K 0.02% 104
2023
Q3
$698K Sell
37,664
-14,095
-27% -$329K 0.02% 105
2023
Q2
$1.31M Sell
51,759
-51,355
-50% -$1.29M 0.04% 96
2023
Q1
$2.52M Sell
103,114
-45,404
-31% -$1.22M 0.08% 79
2022
Q4
$3.54M Sell
148,518
-28,972
-16% -$781K 0.13% 66
2022
Q3
$4.66M Sell
177,490
-181,359
-51% -$6.36M 0.2% 63
2022
Q2
$12.3M Sell
358,849
-157,563
-31% -$6.69M 0.35% 41
2022
Q1
$37.7M Buy
516,412
+407,886
+376% +$29.4M 1.11% 17
2021
Q4
$9.78M Sell
108,526
-32,576
-23% -$3.89M 0.28% 47
2021
Q3
$17.8M Buy
141,102
+95,419
+209% +$13.9M 0.41% 36
2021
Q2
$7.83M Buy
45,683
+24,229
+113% +$3.93M 0.17% 51
2021
Q1
$3.75M Buy
+21,454
New +$4.98M 0.09% 63

Other funds holding TDOC

Sumitomo Mitsui Financial Group's TDOC Position: Q4 2024 in Review

Sumitomo Mitsui Financial Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 4,970 shares — an estimated $42K sold.

Sumitomo Mitsui Financial Group first reported a position in TDOC in Q1 2021 and held it in 15 quarters. The position peaked at $37.7M in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Sumitomo Mitsui Financial Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Sumitomo Mitsui Financial Group sold 4,970 Teladoc Health shares in Q4 2024, an estimated $42K.
  • Sumitomo Mitsui Financial Group first reported a position in Teladoc Health in Q1 2021 and held it in 15 quarters.
  • Sumitomo Mitsui Financial Group's Teladoc Health position peaked at $37.7M in Q1 2022.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q4 2024, filed 13 Feb 2025.